Esperion Therapeutics, Inc.
← Back to ESPR Overview

Esperion Therapeutics, Inc. (ESPR)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-6.85

Financial Fundamentals

ESPRQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2000-03-31-1.86
2000-06-30-0.18
2000-09-30-0.71
2000-12-31-1.37
2001-03-31-2.25
2001-06-30-2.13
2001-09-30-2.32
2001-12-31-2.31
2002-03-31-2.07
2002-06-30-1.94
2002-09-30-2.17
2002-12-31-2.29
2003-03-31-2.06
2003-06-30-1.81
2003-09-30-2.55
2012-03-31-14.50
2012-06-30-10.98
2012-09-30-10.36
2012-12-31-12.50
2013-03-31-12.50
2013-06-30-7.45
2013-09-30-13.87
2013-12-31-5.45
2014-03-31-7.41
2014-06-30-6.60
2014-09-30-9.55
2014-12-31-20.63
2015-03-31-41.34
2015-06-30-37.16
2015-09-30-10.35
2015-12-31-9.59
2016-03-31-6.50
2016-06-30-3.98
2016-09-30-4.50
2016-12-31-2.45
2017-03-31-4.90
2017-06-30-6.03
2017-09-30-6.74
2017-12-31-11.43
2018-03-31-10.45
2018-06-30-5.73
2018-09-30-6.09
2018-12-31-5.13
2019-03-313.08
2019-06-30-5.67
2019-09-30-3.64
2019-12-31-6.60
2020-03-31-2.78
2020-06-302.85
2020-09-30-3.03
2020-12-31-1.67
2021-03-31-2.00
2021-06-30-3.17
2021-09-30-1.15
2021-12-31-0.71
2022-03-31-1.00
2022-06-30-1.25
2022-09-30-1.66
2022-12-31-1.67
2023-03-31-0.35
2023-06-30-0.76
2023-09-30-0.66
2023-12-31-1.50
2024-03-311.94
2024-06-30-1.77
2024-09-30-2.75
2024-12-31-5.00
2025-03-31-1.71
2025-06-30-10.17
2025-09-30-4.14
2025-12-313.56
2026-03-31-6.85

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.